Clinical Research Directory

Inclusion Criteria 1. Between the ages of 8-18 years 2. Within 14 weeks of type 1 diabetes diagnosis 3. Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device. Exclusion Criteria Children will be ineligible to participate in the study if they meet any of the following: 1. Other cardiometabolic or endocrine diseases diagnosis (type 2 diabetes; familial disorders of cholesterol metabolism; lupus) 2. Other genetic syndromes (Down Syndrome; Prader-Willi) 3. Eating disorder diagnosis 4. Transgender children taking hormone blockers or exogenous sex steroids 5. Currently treated with medications known to affect metabolism (e.g. glucocorticoids, antipsychotics).